Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-nams
/
NewAmsterdam Pharma Company NV
NAMS
Add to Watchlist
33.890
USD
+0.020
+0.06%
Close 06/30, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/01, 09:30 (ET)
3.96B
Market Cap
Loss
P/E TTM
NewAmsterdam Pharma Company NV
33.890
+0.020
+0.06%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Wed, May 13
Updated: Wed, May 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
14.49%
Capital World Investors
8.54%
RA Capital Management, LP
8.17%
Forbion Capital Partners
7.87%
Fidelity Management & Research Company LLC
5.03%
Other
55.90%
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
14.49%
Capital World Investors
8.54%
RA Capital Management, LP
8.17%
Forbion Capital Partners
7.87%
Fidelity Management & Research Company LLC
5.03%
Other
55.90%
Shareholder Types
Shareholders
Proportion
Investment Advisor
29.84%
Investment Advisor/Hedge Fund
20.74%
Venture Capital
19.33%
Private Equity
14.49%
Hedge Fund
12.38%
Family Office
2.63%
Research Firm
2.49%
Individual Investor
0.99%
Sovereign Wealth Fund
0.97%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
366
128.70M
110.09%
+2.43M
2025Q4
317
118.25M
104.29%
-6.54M
2025Q3
283
121.74M
107.54%
+4.12M
2025Q2
263
127.89M
114.87%
+4.67M
2025Q1
255
126.71M
112.87%
+7.17M
2024Q4
216
108.34M
98.72%
+13.96M
2024Q3
194
82.73M
88.90%
-12.05M
2024Q2
184
81.92M
90.19%
-12.22M
2024Q1
155
81.92M
90.50%
-4.21M
2023Q4
117
72.34M
86.57%
-9.73M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Frazier Life Sciences Management, L.P.
16.94M
14.74%
+241.82K
+1.45%
Dec 31, 2025
Capital World Investors
9.98M
8.68%
+161.29K
+1.64%
Dec 31, 2025
RA Capital Management, LP
9.55M
8.31%
-588.75K
-5.81%
Dec 31, 2025
Forbion Capital Partners
9.20M
8%
-13.48K
-0.15%
Dec 31, 2025
Fidelity Management & Research Company LLC
5.87M
5.11%
+480.89K
+8.92%
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
5.67M
4.93%
-4.80M
-45.83%
Dec 31, 2025
Wellington Management Company, LLP
5.03M
4.38%
+1.01M
+25.20%
Dec 31, 2025
Viking Global Investors LP
4.20M
3.66%
-2.27M
-35.09%
Dec 31, 2025
Deerfield Management Company, L.P.
4.16M
3.62%
-101.90K
-2.39%
Dec 31, 2025
Duquesne Family Office LLC
3.07M
2.67%
+1.15M
+59.60%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X Guru Index ETF
1.82%
ALPS Medical Breakthroughs ETF
1.81%
Virtus LifeSci Biotech Clinical Trials ETF
1.22%
First Trust Small Cap Growth AlphaDEX Fund
1.05%
First Trust NASDAQ Pharmaceuticals ETF
0.83%
Capital Group US Small and Mid Cap ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
0.55%
First Trust Small Cap Core Alphadex Fund
0.43%
Invesco Nasdaq Biotechnology ETF
0.42%
View more
Global X Guru Index ETF
Proportion
1.82%
ALPS Medical Breakthroughs ETF
Proportion
1.81%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
1.22%
First Trust Small Cap Growth AlphaDEX Fund
Proportion
1.05%
First Trust NASDAQ Pharmaceuticals ETF
Proportion
0.83%
Capital Group US Small and Mid Cap ETF
Proportion
0.68%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion
0.55%
First Trust Small Cap Core Alphadex Fund
Proportion
0.43%
Invesco Nasdaq Biotechnology ETF
Proportion
0.42%